Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2019 | An update on NSGO

Mansoor Mirza • 1 Oct 2019
ESMO 2019
General Gynecological Cancer

Mansoor Raza Mirza, MD, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark provides an update on the Nordic Society of Gynaecologic Oncology (NSGO) and its work in clinical trials.This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

More from Mansoor Mirza

Highlights in gynecological cancers at ESMO 2023
3:23
Highlights in gynecological cancers at ESMO 2023
Mansoor Mirza • 22 Oct 2023
Dostarlimab + chemo in pA/rEC: PFS & OS by molecular classification in ENGOT-EN6-NSGO/GOG-3031/RUBY
5:01
Dostarlimab + chemo in pA/rEC: PFS & OS by molecular classification in ENGOT-EN6-NSGO/GOG-3031/RUBY
Mansoor Mirza • 22 Oct 2023
Long-term benefit from 1L maintenance PARP inhibitors in ovarian cancer
2:11
Long-term benefit from 1L maintenance PARP inhibitors in ovarian cancer
Mansoor Mirza • 29 Sep 2022
Optimal management of recurrent low grade endometrial cancer
4:15
Optimal management of recurrent low grade endometrial cancer
Mansoor Mirza • 29 Sep 2022

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026
The content of VJOncology is intended for healthcare professionals